Cargando…
Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis
BACKGROUND: Iron-deficiency anemia and iron deficiency are common comorbidities associated with inflammatory bowel disease (IBD) resulting in impaired quality of life and high health care costs. Intravenous iron has shown clinical benefit compared to oral iron therapy. AIM: This study aimed to compa...
Autores principales: | Stein, Jürgen, Haas, Jennifer Scarlet, Ong, Siew Hwa, Borchert, Kathrin, Hardt, Thomas, Lechat, Elmira, Nip, Kerry, Foerster, Douglas, Braun, Sebastian, Baumgart, Daniel C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804284/ https://www.ncbi.nlm.nih.gov/pubmed/29440920 http://dx.doi.org/10.2147/CEOR.S150900 |
Ejemplares similares
-
Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
por: Theidel, Ulrike, et al.
Publicado: (2017) -
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020) -
Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015) -
Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011) -
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)